Drug Type Small molecule drug |
Synonyms L-citrulline + allopurinol |
Target |
Mechanism XO inhibitors(Xanthine dehydrogenase inhibitors), Nitric oxide donors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Dr. Noah Biotech Co., Ltd.Startup |
Active Organization Dr. Noah Biotech Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC5H4N4O |
InChIKeyOFCNXPDARWKPPY-UHFFFAOYSA-N |
CAS Registry315-30-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophy, Duchenne | Preclinical | US | Dr. Noah Biotech Co., Ltd.Startup | 30 Apr 2024 |